首页> 美国卫生研究院文献>Journal of Clinical Medicine >Delta Neutrophil Index for the Prediction of Prognosis in Acute Gastrointestinal Diseases; Diagnostic Test Accuracy Meta-Analysis
【2h】

Delta Neutrophil Index for the Prediction of Prognosis in Acute Gastrointestinal Diseases; Diagnostic Test Accuracy Meta-Analysis

机译:Delta Neutrophil Index用于预测急性胃肠道疾病的预后;诊断测试准确度荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Delta neutrophil index (DNI) is a novel diagnostic and prognostic biomarker of various infectious or inflammatory conditions. However, data on optimal measurement time are scarce, and no studies have evaluated the potential role of the DNI as a prognostic biomarker of gastrointestinal diseases with diagnostic test accuracy meta-analysis. Core databases were searched. The inclusion criteria were as follows: patients who have gastrointestinal diseases and DNI measurements presenting diagnostic indices for predicting the prognosis, including severity, surgical outcomes, and mortality from gastrointestinal diseases. We identified twelve studies for the systematic review and ten studies for the quantitative analysis. Pooled area under the curve, sensitivity, specificity, and diagnostic odds ratio of DNI at the initial admission date were 0.82 (95% confidence interval: 0.78–0.85), 0.75 (0.52–0.89), 0.76 (0.63–0.86), and 10 (3–35), respectively. Meta-regression showed no reasons for heterogeneity and publication bias was not detected. Fagan’s nomogram indicated that the posterior probability of ‘poor prognosis’ was 76% if the test was positive, and ‘no poor prognosis’ was 25% if the test was negative. The DNI can be considered as a reliable initial measurement biomarker for predicting prognosis in patients with gastrointestinal diseases,
机译:Delta中性粒细胞指数(DNI)是各种感染或炎性疾病的新型诊断和预后生物标志物。然而,关于最佳测量时间的数据很少,并且尚无研究通过诊断测试准确性荟萃分析评估DNI作为胃肠道疾病预后生物标志物的潜在作用。搜索核心数据库。纳入标准如下:患有胃肠道疾病和DNI测量值的患者具有可预测预后的诊断指标,包括严重程度,手术结局和胃肠道疾病的死亡率。我们确定了十二项研究用于系统评价,十项研究用于定量分析。首次入院时曲线下的合并区域,DNI的敏感性,特异性和诊断比值比分别为0.82(95%置信区间:0.78-0.85),0.75(0.52-0.89),0.76(0.63-0.86)和10 (3–35)。元回归表明没有异质性的原因,也没有发现出版偏倚。 Fagan的列线图显示,如果检测结果为阳性,则“不良预后”的后验概率为76%,如果检测结果为阴性,则“无不良预后”的后验概率为25%。 DNI可被视为预测胃肠道疾病患者预后的可靠初始测量生物标志物,

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号